QUOTED. 18 September 2020. Ed Israelski.
The US FDA has been skeptical about remote testing, but independent consultant (and former Abbott human factors director) Ed Israelski predicts the pandemic may bring a change.
“It seems to me that FDA will have to start accepting more remote tests for summative, otherwise things will come to a grinding halt in terms of new products – other than those that get emergency use authorizations.” — Ed Israelski, independent consultant
- Find out more: Human Factors Experts Forge Ahead With ‘Tricky’ In-Person Studies In The Age Of Coronavirus
Click here for a free trial of Medtech Insight